Literature DB >> 25649507

The membrane proximal external regions of gp41 from HIV-1 strains HXB2 and JRFL have different sensitivities to alanine mutation.

Hyun Ah Yi1, Barbara Diaz-Rohrer, Priyanka Saminathan, Amy Jacobs.   

Abstract

The transmembrane subunit (gp41) of the HIV envelope protein complex (Env) mediates the viral fusion step of HIV entry. The membrane proximal external region (MPER), one of the functional domains of gp41, has been the focus of a great deal of research because it is a target for neutralizing antibodies. In this study, we examined 23 amino acid residues in the MPER (660-683) in both a CXCR4 coreceptor-utilizing strain (HXB2) and a CCR5-utilizing strain (JRFL) by alanine scanning mutagenesis. Despite the high degree of gp41 sequence conservation, the effects of alanine mutation in the MPER were different between the two strains. Most mutations in HXB2 had fusogenicity and protein expression levels not less than 50% of that of the wild type in the case of cell-cell fusion. However, ∼30% of the mutants in HXB2 showed a severe defect in fusogenicity in viral entry. Mutations in the MPER of strain JRFL had more dramatic effects than that in HXB2 in cell-cell fusion and viral entry. The fact that there are large differences in the effects of mutation between two strains suggests the potential for the interaction of the MPER with nonconserved sequences such as the fusion peptide and/or other NHR domains as well as potential long-range structural effects on the conformational changes that occur with the Env complex during membrane fusion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25649507      PMCID: PMC4684184          DOI: 10.1021/bi501171r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  68 in total

1.  Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding.

Authors:  U O'Doherty; W J Swiggard; M H Malim
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Core structure of gp41 from the HIV envelope glycoprotein.

Authors:  D C Chan; D Fass; J M Berger; P S Kim
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

3.  Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.

Authors:  J He; S Choe; R Walker; P Di Marzio; D O Morgan; N R Landau
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

4.  Identification of a cis-acting element in human immunodeficiency virus type 2 (HIV-2) that is responsive to the HIV-1 rev and human T-cell leukemia virus types I and II rex proteins.

Authors:  N Lewis; J Williams; D Rekosh; M L Hammarskjöld
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1.

Authors:  E J Platt; K Wehrly; S E Kuhmann; B Chesebro; D Kabat
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

6.  Crystal structure of HIV-1 gp41 including both fusion peptide and membrane proximal external regions.

Authors:  Victor Buzon; Ganesh Natrajan; David Schibli; Felix Campelo; Michael M Kozlov; Winfried Weissenhorn
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

7.  HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes.

Authors:  Kosuke Miyauchi; Yuri Kim; Olga Latinovic; Vladimir Morozov; Gregory B Melikyan
Journal:  Cell       Date:  2009-05-01       Impact factor: 41.582

8.  Human immunodeficiency virus infection of CD4-bearing cells occurs by a pH-independent mechanism.

Authors:  M O McClure; M Marsh; R A Weiss
Journal:  EMBO J       Date:  1988-02       Impact factor: 11.598

9.  Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies.

Authors:  Irene A Abela; Livia Berlinger; Merle Schanz; Lucy Reynell; Huldrych F Günthard; Peter Rusert; Alexandra Trkola
Journal:  PLoS Pathog       Date:  2012-04-05       Impact factor: 6.823

10.  Neutralisation of HIV-1 cell-cell spread by human and llama antibodies.

Authors:  Laura E McCoy; Elisabetta Groppelli; Christophe Blanchetot; Hans de Haard; Theo Verrips; Lucy Rutten; Robin A Weiss; Clare Jolly
Journal:  Retrovirology       Date:  2014-10-02       Impact factor: 4.602

View more
  5 in total

1.  Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer.

Authors:  Bibek Parajuli; Kriti Acharya; Reina Yu; Brendon Ngo; Adel A Rashad; Cameron F Abrams; Irwin M Chaiken
Journal:  Biochemistry       Date:  2016-10-27       Impact factor: 3.162

2.  Cell-cell and virus-cell fusion assay-based analyses of alanine insertion mutants in the distal α9 portion of the JRFL gp41 subunit from HIV-1.

Authors:  Mizuki Yamamoto; Qingling Du; Jiping Song; Hongyun Wang; Aya Watanabe; Yuetsu Tanaka; Yasushi Kawaguchi; Jun-Ichiro Inoue; Zene Matsuda
Journal:  J Biol Chem       Date:  2019-02-08       Impact factor: 5.157

3.  HIV-1 Env gp41 Transmembrane Domain Dynamics Are Modulated by Lipid, Water, and Ion Interactions.

Authors:  Louis R Hollingsworth; Justin A Lemkul; David R Bevan; Anne M Brown
Journal:  Biophys J       Date:  2018-07-03       Impact factor: 4.033

4.  Characterizing the Murine Leukemia Virus Envelope Glycoprotein Membrane-Spanning Domain for Its Roles in Interface Alignment and Fusogenicity.

Authors:  Daniel J Salamango; Marc C Johnson
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

5.  HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.

Authors:  Alexis Kafando; Christine Martineau; Mohamed El-Far; Eric Fournier; Florence Doualla-Bell; Bouchra Serhir; Adama Kazienga; Mohamed Ndongo Sangaré; Mohamed Sylla; Annie Chamberland; Hugues Charest; Cécile L Tremblay
Journal:  Viruses       Date:  2019-11-01       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.